trastuzumab,neratinib
roche,puma
['neratinib', 'summit', 'puma', '$pbyi']
first out// $pbyi: puma biotechnology announced updated findings from the phase ii summit basket trial of neratinib for her2-mutant, recurrent/metastatic cervical cancer at the esmo congress
News platform.
Real-time market news alerts.